Novartis’ Cosentyx chases Lilly’s just-approved Taltz with long-term data in spondyloarthritis kblankenship Thu, 06/04/2020 – 10:27 More: Novartis' Cosentyx chases Lilly's just-approved Taltz with long-term data in spondyloarthritis Source: fierce
read moreRemdesivir stockpiling could help push COVID drug into profitable territory for Gilead: analyst arlene.weintraub Thu, 06/04/2020 – 09:52 More: Remdesivir stockpiling could help push COVID drug into profitable territory for Gilead: analyst Source: fierce
read moreACT MySelf, was developed by Biogen in collaboration with people living with MS, the MS Trust, a team of MS specialist nurses and an MS clinical psychologist More: Biogen launches digital self-help tool to support mental health in MS Source:
read moreOne in seven UK adults is affected by migraine More: NICE publishes final guidance backing Teva's Ajovy for migraine Source: News
read moreThese proteins control various aspects of RNA biology and represent a new target for cancer treatment More: AZ, Accent to develop therapies targeting RNA-modifying proteins Source: News
read moreHowever, the trial did have limitations, researchers note More: Hydroxychloroquine fails as postexposure prophylaxis for COVID-19 Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals